Advancing Clinical Research in Primary Glomerular Diseases

The NIH/NIDDK is soliciting proposals to support translational and clinical research that promotes therapeutic development for primary glomerular diseases. The emphasis of this FOA is specifically on chronic forms of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), immunoglobulin A nephropathy (IGAN), and idiopathic membranous nephropathy (IMN).

This is a limited submission opportunity; the University may submit one (1) grant application under this announcement. Interested faculty must submit an abstract, CV, and budget to Dean Puzas via Catherine Muzytchuk (Catherine_muzytchuk@urmc.rochester.edu) by November 16th, using the words “Glomerular Disease” in the subject line. The Deans will select a candidate by November 26th.

The complete program solicitation can be found here. The deadline for the optional Letter of Intent is January 27, 2013. The full proposal is due February 27, 2013. It is important to remember that ORPA must receive electronic proposals five (5) business days prior to the sponsor’s deadline, along with a completed and signed University sign-off form.

 

NIH Funding Acknowledgement ** Important ** All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH FUNDING ACKNOWLEDGEMENT and must comply with the NIH Public Access Policy.